Related Experiment Video
Updated: Jun 18, 2026

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026
Segmental versus extended colectomy for colonic Crohn's disease in advanced therapy era: a systematic review and
L M Delgado1, B F Pompeu2,3, L M Peñaranda4
1Faculdade de Medicina da Universidade Federal de Minas Gerais, Av. Prof. Alfredo Balena, 190 - Santa Efigênia, Belo Horizonte, MG, 30130-100, Brazil. ldelgado@ufmg.br.
Background:
The optimal extent of resection for colonic Crohn's disease (CD) remains controversial. Segmental colectomy (SC) may preserve bowel and avoid permanent stoma but has been historically associated with higher recurrence than extended colectomy (EC). In the advanced therapy era, contemporary data and Bayesian methods may refine this risk-benefit balance.
Methods:
PubMed, Embase, and Cochrane Library were searched from inception to December 1, 2025. The primary outcome was surgical recurrence; secondary outcomes were reoperation, permanent stoma, overall postoperative complications, and mortality. Frequentist random-effects models (restricted maximum likelihood) were used to pool odds ratios (ORs) with 95% confidence intervals (CIs), with heterogeneity assessed by I2 and leave-one-out analyses. Bayesian random-effects meta-analyses (bayesmeta) were performed for surgical recurrence, reoperation, and permanent stoma using vague priors and empiric Turner priors for heterogeneity, with additional models incorporating historical evidence from the advanced therapy era.
Results:
Five observational studies (1095 patients; 501 SC, 594 EC) were included. Surgical recurrence did not differ significantly between SC and EC (OR 1.15; 95% CI 0.53-2.50; I2 = 74%). Reoperation (OR 1.36; 95% CI 0.71-2.61; I2 = 68%), permanent stoma (OR 0.22; 95% CI 0.03-1.39; I2 = 87%), and overall complications (OR 0.75; 95% CI 0.40-1.40; I2 = 64%) were also not significantly different. Mortality was reported in one study (1 SC vs 5 EC). Bayesian models suggested a higher probability of surgical recurrence and reoperation after SC but with wide credible intervals and substantial heterogeneity, whereas SC showed a consistently high probability of reducing permanent stoma risk (posterior OR ~ 0.23; P[OR ≤ 1] > 0.95 in primary models; reinforced by historical priors). Leave-one-out analyses identified influential studies for some outcomes but did not materially alter the overall interpretation. All studies had a moderate risk of bias, mainly due to confounding and selection.
Conclusion:
In contemporary observational evidence, SC and EC show broadly comparable outcomes for surgical recurrence, reoperation, complications, and mortality, while SC is strongly favored with respect to permanent stoma avoidance. Operative decision-making should weigh a probable increase in recurrence risk after SC against the clinically meaningful functional benefit of stoma preservation, recognizing the limitations imposed by observational designs, heterogeneity, and sparse data.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
